3040 POSTER Optimal dose for an every 2 week (q2w) cetuximab (C) regimen in patients (pts) with metastatic colorectal cancer (mCRC): a phase I safety, pharmacokinetics (PK) and pharmacodynamics (PD) study of weekly (q1w) and q2w schedules

F.Ciardiello; A.Cervantes; M.Vega-Villegas; E.Casado; E.Rodriguez-Braun; E.Martinelli; F.Rojo; J.Baselga; O.Kisker; J.Tabernero

首页> 外文期刊>European Journal of Cancer Supplements >3040 POSTER Optimal dose for an every 2 week (q2w) cetuximab (C) regimen in patients (pts) with metastatic colorectal cancer (mCRC): a phase I safety, pharmacokinetics (PK) and pharmacodynamics (PD) study of weekly (q1w) and q2w schedules

【24h】

3040 POSTER Optimal dose for an every 2 week (q2w) cetuximab (C) regimen in patients (pts) with metastatic colorectal cancer (mCRC): a phase I safety, pharmacokinetics (PK) and pharmacodynamics (PD) study of weekly (q1w) and q2w schedules

机译：3040 POSTER转移性结直肠癌（mCRC）患者（pts）的西妥昔单抗（C）方案每2周（q2w）的最佳剂量：每周（q1w）的I期安全性，药代动力学（PK）和药效学（PD）研究和q2w时间表

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第4期|共1页
作者
F.Ciardiello; A.Cervantes; M.Vega-Villegas; E.Casado; E.Rodriguez-Braun; E.Martinelli; F.Rojo; J.Baselga; O.Kisker; J.Tabernero;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献

1. 3017 POSTER Cetuximab dose-escalation in patients (pts) with metastatic colorectal cancer (mCRC) with no or slight skin reactions on standard treatment: pharmacokinetic (PK), pharmacodynamic (PD) and efficacy data from the EVEREST study [J] . Y.Humblet, M.Peeters, H.Gelderblom, European Journal of Cancer Supplements . 2007,第4期

机译：在标准治疗下无或有轻微皮肤反应的转移性结直肠癌（mCRC）患者（pts）中的3017 POSTER西妥昔单抗剂量递增：EVEREST研究的药代动力学（PK），药效学（PD）和功效数据
2. 3067 POSTER Irinotecan Metronomic Chemotherapy (MC) in patients with diagnosis of metastatic colorectal cancer (MCRC): clinical, pharmacodynamic (PD) and pharmacokinetic (PK) evaluation [J] . G.Baldi, G.Bocci, M.T.Barletta, European Journal of Cancer Supplements . 2007,第4期

机译：诊断转移性大肠癌（MCRC）的患者的3067 POSTER伊立替康节律化疗（MC）：临床，药效学（PD）和药代动力学（PK）评估
3. 2125 POSTER Phase I-II study of IV vinorelbine (VRL) and oxaliplatin (OXP) every two weeks (q2w) in metastatic breast cancer (MBC): Interim results of the phase II trial [J] . A.Guerrero, A.Rodriguez-Lescure, L.Calvo, European Journal of Cancer Supplements . 2007,第4期

机译：在转移性乳腺癌（MBC）中每两周（q2w）进行静脉内长春瑞滨（VRL）和奥沙利铂（OXP）的2125 POSTER I-II期研究：II期试验的中期结果
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. BIO89-100 Demonstrated Robust Reductions in Liver Fat and Liver Fat Volume (LFV) by MRI-PDFF Favorable Tolerability and Potential for Weekly (QW) or Every 2 Weeks (Q2W) Dosing in a Phase 1b/2a Placebo-Controlled Double-Blind Multiple Ascending Dose Study in NASH [O] . Juan Pablo Frias, Eric J Lawitz, Grisell Ortiz-LaSanta, 2021

机译：Bio89-100通过MRI-PDFF的肝脏脂肪和肝脂肪量（LFV）稳健降低每周（QW）或每2周（Q2W）在阶段1B / 2A安慰剂控制双层中给药双重盲人纳什的多个上升剂量研究
7. BIO89-100 Demonstrated Robust Reductions in Liver Fat and Liver Fat Volume (LFV) by MRI-PDFF, Favorable Tolerability and Potential for Weekly (QW) or Every 2 Weeks (Q2W) Dosing in a Phase 1b/2a Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in NASH [O] . Juan Pablo Frias, Eric J Lawitz, Grisell Ortiz-LaSanta, 2021

机译：Bio89-100通过MRI-PDFF的肝脏脂肪和肝脂肪量（LFV）稳健降低，每周（QW）或每2周（Q2W）在阶段1B / 2A安慰剂控制，双层中给药，双重盲人，纳什的多个上升剂量研究

3040 POSTER Optimal dose for an every 2 week (q2w) cetuximab (C) regimen in patients (pts) with metastatic colorectal cancer (mCRC): a phase I safety, pharmacokinetics (PK) and pharmacodynamics (PD) study of weekly (q1w) and q2w schedules

著录项

相似文献

相关主题

期刊订阅